Evaluate Pembrolizumab (Keytruda): CADTH Reimbursement Advice: Indicator: Together with chemotherapy, for the treatment method of adult patients with locally recurrent unresectable or metastatic triple-unfavorable breast cancer who have not received prior chemotherapy for metastatic disease and whose tumours Categorical programmed mobile Loss of life-ligand 1 (combined positive rating... https://pembrolizumab-cost61493.angelinsblog.com/35066033/little-known-facts-about-pembrolizumab-cost